Challenges to Laboratory Monitoring of Direct Oral Anticoagulants
Direct oral anticoagulants (DOACs) exert anticoagulation effect by directly inhibiting Factor Xa (rivaroxaban, apixaban, and edoxaban) or thrombin (dabigatran). Though DOACs are characterized by fixed-dose prescribing and generally do not require routine laboratory drug-level monitoring (DLM), circu...
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publishing
2024-03-01
|
| סדרה: | Clinical and Applied Thrombosis/Hemostasis |
| גישה מקוונת: | https://doi.org/10.1177/10760296241241524 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|